Alligator Bioscience launches ALLIGATOR-FAB™ – a novel human antibody library
Lund, Sweden, December 10, 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced the completion of a novel proprietary human synthetic antibody library in Fab (Fragment antigen-binding) format – ALLIGATOR-FAB™. The design of the library and antibody diversity has been optimized to ensure the development of highly functional antibodies with excellent developability properties. The ALLIGATOR-FAB library is built on multiple antibody backbones with optimal drug development properties to further increase the structural diversity of generated antibodies. The ALLIGATOR-FAB